DISPOSITION OF INTRAVENOUS PROPYLTHIOURACIL

被引：14

作者：

GILES, HG

ROBERTS, EA

ORREGO, H

SELLERS, EM

机构：

[1] ADDICT RES FDN,PROGRAM GASTROENTEROL,TORONTO M5S 2S1,ONTARIO,CANADA

[2] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A1,ONTARIO,CANADA

[3] UNIV TORONTO,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 21卷 / 11-1期

关键词：

D O I：

10.1002/j.1552-4604.1981.tb05651.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：466 / 471

页数：6

共 18 条

[1] METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN [J].

ALEXANDER, WD ;

EVANS, V ;

MACAULAY, A ;

GALLAGHER, TF ;

LONDONO, J .

BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652) :290-+

[2]

EICHELBAUM M, 1976, Clinical Pharmacokinetics, V1, P339, DOI 10.2165/00003088-197601050-00002

[3]

GIBALDI M, 1975, PHARMACOKINETICS

[4] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PLASMA PROPYLTHIOURACIL [J].

GILES, HG ;

MILLER, R ;

SELLERS, EM .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (11) :1459-1460

[5]

GILES HG, 1979, FED PROC, V38, P528

[6]

GILES HG, 1980, FED PROC, V39, P851

[7]

GUINUP G, 1978, JAMA, V239, P2457

[8]

KAMPMANN J, 1974, ACTA PHARMACOL TOX, V35, P361

[9]

KAMPMANN J, 1975, ACTA PHARMACOL TOX, V37, P201

[10] PHARMACOKINETICS OF PROPYLTHIOURACIL IN MAN AFTER INTRAVENOUS-INFUSION [J].

KAMPMANN, JP .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (05) :435-443

← 1 2 →